Clinical Trial Update: The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial is evaluating a topical formulation containing Physalis angulata (ciplukan) for psoriasis vulgaris, with enrollment by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Topical formulation containing Ciplukan (Physalis angulata Linn.) (Physalis angulata extract topical formulation)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Psoriasis Vulgaris, Inflammation | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION